Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC
- PMID: 23536707
- DOI: 10.1158/1541-7786.MCR-12-0652
Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC
Abstract
Patients with non-small cell lung cancer (NSCLC) that harbors epidermal growth factor receptor (EGFR) mutations initially respond to EGFR-tyrosine kinase inhibitors (TKI) but eventually experience relapse. Acquired resistance to EGFR-TKIs is strongly associated with patient mortality. Thus, elucidation of the mechanism of acquired resistance to EGFR-TKIs is of great importance. In this study, gefitinib-resistant cell line models were established by long-term exposure to gefitinib using the gefitinib-sensitive lung cancer cell lines, PC9 and HCC827. Expression analyses indicated that both FGFR1 and FGF2 were increased in PC9 gefitinib-resistant (PC9 GR) cells as compared with PC9 naïve (PC9 na) cells. Importantly, proliferation of gefitinib-resistant cells was dependent on the FGF2 -FGFR1 pathway. Mechanistically, inhibition of either FGF2 or FGFR1 by siRNA or FGFR inhibitor (PD173074) restored gefitinib sensitivity in PC9 GR cells. These data suggest that FGF2 -FGFR1 activation through an autocrine loop is a novel mechanism of acquired resistance to EGFR-TKIs.
©2013 AACR
Similar articles
-
Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.Mol Med Rep. 2014 Aug;10(2):931-8. doi: 10.3892/mmr.2014.2243. Epub 2014 May 16. Mol Med Rep. 2014. PMID: 24840891
-
Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.Eur J Cancer. 2013 Nov;49(16):3559-72. doi: 10.1016/j.ejca.2013.07.007. Epub 2013 Aug 2. Eur J Cancer. 2013. PMID: 23916913
-
Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells.Mol Med Rep. 2014 Jun;9(6):2417-22. doi: 10.3892/mmr.2014.2082. Epub 2014 Mar 28. Mol Med Rep. 2014. PMID: 24682085
-
Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer.Clin Lung Cancer. 2013 Jul;14(4):322-32. doi: 10.1016/j.cllc.2012.12.001. Epub 2013 Jan 16. Clin Lung Cancer. 2013. PMID: 23332287 Review.
-
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).Int J Mol Med. 2007 Jul;20(1):3-10. Int J Mol Med. 2007. PMID: 17549382 Review.
Cited by
-
A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis.Int J Biol Sci. 2018 Jul 27;14(10):1389-1398. doi: 10.7150/ijbs.24739. eCollection 2018. Int J Biol Sci. 2018. PMID: 30123084 Free PMC article.
-
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance.Cancers (Basel). 2021 Nov 18;13(22):5796. doi: 10.3390/cancers13225796. Cancers (Basel). 2021. PMID: 34830951 Free PMC article. Review.
-
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.Nat Commun. 2019 Apr 18;10(1):1812. doi: 10.1038/s41467-019-09734-5. Nat Commun. 2019. PMID: 31000705 Free PMC article.
-
RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivation.Cell Death Dis. 2018 May 22;9(6):587. doi: 10.1038/s41419-018-0651-5. Cell Death Dis. 2018. PMID: 29789542 Free PMC article.
-
Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC.Pharmaceuticals (Basel). 2022 Nov 15;15(11):1411. doi: 10.3390/ph15111411. Pharmaceuticals (Basel). 2022. PMID: 36422541 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
